Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors

被引：33

作者：

Li, Ning ^{[1
,2
,3
,4
]}

Wang, Li-Jun ^{[1
,2
,4
]}

Jiang, Bo ^{[1
,2
,4
]}

Guo, Shu-Ju ^{[1
,2
,4
]}

Li, Xiang-Qian ^{[1
,2
,4
]}

Chen, Xue-Chun ^{[5
]}

Luo, Jiao ^{[1
,2
,3
,4
]}

Li, Chao ^{[1
,2
,3
,4
]}

Wang, Yi ^{[5
]}

Shi, Da-Yong ^{[1
,2
,3
,4
]}

机构：

[1] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China

[2] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Drugs & Bioprod, Qingdao 266235, Peoples R China

[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China

[4] Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao 266071, Peoples R China

[5] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2018年 / 28卷 / 12期

基金：

中国国家自然科学基金; 美国国家科学基金会;

关键词：

Pyrimidinedionederivatives; DPP-4; inhibitor; Molecular hybrid; SARs; Type; 2; diabetes; ALGA RHODOMELA-CONFERVOIDES; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; PHOSPHATASE 1B INHIBITOR; C57BL/KSJ-DB/DB MICE; BROMOPHENOLS; DISCOVERY; HPN;

D O I：

10.1016/j.bmcl.2018.05.022

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of novel pyrimidinedione derivatives were designed and evaluated for in vitro dipeptidyl peptidase-4 (DPP-4) inhibitory activity and in vivo anti-hyperglycemic efficacy. Among them, the representative compounds 11, 15 and 16 showed excellent inhibitory activity of DPP-4 with IC50 values of 64.47 nM, 188.7 nM and 65.36 nM, respectively. Further studies revealed that compound 11 was potent in vivo hypoglycemic effect. The structure-activity relationships of these pyrimidinedione derivatives had been discussed, which would be useful for developing novel DPP-4 inhibitors as treating type 2 diabetes.

引用

页码：2131 / 2135

页数：5

共 23 条

[1] An update on DPP-4 inhibitors in the management of type 2 diabetes [J].

Cahn, Avivit ;

Cernea, Simona ;

Raz, Itamar .

EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (04) :409-419

[2] Synthesis and protein tyrosine phosphatase 1B inhibition activities of two new synthetic bromophenols and their methoxy derivatives [J].

Cui Yongchao ;

Shi Dayong ;

Hu Zhiqiang .

CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY, 2011, 29 (06) :1237-1242

[3] BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS [J].

DEACON, CF ;

NAUCK, MA ;

TOFTNIELSEN, M ;

PRIDAL, L ;

WILLMS, B ;

HOLST, JJ .

DIABETES, 1995, 44 (09) :1126-1131

[4]

Ebert R, 1987, DIABETES-METAB RES, V3, P185

[5]

Fan X, 2003, CHINESE CHEM LETT, V14, P939

[6] Bromophenols from the red alga Rhodomela confervoides [J].

Fan, X ;

Xu, NJ ;

Shi, JG .

JOURNAL OF NATURAL PRODUCTS, 2003, 66 (03) :455-458

[7] Synthesis of three bromophenols from red algae as PTP1B inhibitors [J].

Guo Shuju ;

Li Jing ;

Li Ting ;

Shi Dayong ;

Han Lijun .

CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY, 2011, 29 (01) :68-74

[8]

H D B C B S, 2012, BIOCH PHARM, V83, P823

[9] The physiology of glucagon-like peptide 1 [J].

Holst, Jens Juul .

PHYSIOLOGICAL REVIEWS, 2007, 87 (04) :1409-1439

[10]

Hu HP, 2017, CN106632241A, Patent No. 106632241

← 1 2 3 →